(SOURCE: AMERICAN SOCIETY FOR MICROBIOLOGY) – A clever new tuberculosis vaccine has shown promise in trials in mice. If it succeeds, it will be the first new TB vaccine in a century. With the rise of multidrug resistant tuberculosis, the difficulty of curing the disease, and the large annual death toll, a successful vaccine could be […]
(SOURCE: AMERICAN SOCIETY FOR MICROBIOLOGY) – Aminoglycosides, recommended by the World Health Organization to treat multidrug resistant tuberculosis, cause hearing loss and kidney damage in a dose dependent manner. Now, by reducing the dose in a carefully calculated fashion, Dutch clinician researchers have been able to greatly reduce the numbers of patients suffering hearing loss, without compromising […]
(SOURCE: NIH/NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES) – Findings Could Lead to Improved TB Vaccines for Humans. New research findings provide insight into the immune system pathways that may be key to developing an effective tuberculosis (TB) vaccine. The study, to be published Thursday in the journal Nature Communications, was supported by the National Institute of […]
(SOURCE: MICHIGAN STATE UNIVERSITY) – A centuries-old herbal medicine, discovered by Chinese scientists and used to effectively treat malaria, has been found to potentially aid in the treatment of tuberculosis and may slow the evolution of drug resistance. In a promising study led by Robert Abramovitch, a Michigan State University microbiologist and TB expert, the ancient remedy […]
(SOURCE: JOHNS HOPKINS MEDICINE) – Johns Hopkins researchers have developed a computer simulation that helps predict under which circumstances a new short-course treatment regimen for drug-resistant tuberculosis could substantially reduce the global incidence and spread of the disease. The computer model was developed to help understand the impact of a recommendation issued in May by the World […]
(AMERICAN ASSOCIATION OF PHARMACEUTICAL SCIENTISTS) According to a recent press release, Tuberculosis (TB) is responsible for more than 1.8 million deaths each year, according to the World Health Organization, yet there has been little significant improvement in therapies in the past 20 years. This chronic disease is systemic, meaning it affects not only the lungs […]
(JOHNS HOPKINS MEDICINE) According to a recent press release, researchers at Johns Hopkins report they have laid the foundation to develop novel antibiotics that work against incurable, antibiotic-resistant bacteria like tuberculosis by targeting an enzyme essential to the production and integrity of bacterial cell walls.